These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11205244)

  • 1. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
    Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2000; 20(6B):4171-8. PubMed ID: 11205244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH; Cory JG
    Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L; Cory JG
    Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
    Hall JG; Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2001; 21(1A):173-80. PubMed ID: 11299731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH; Cory JG
    Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
    Somerville L; Cory JG
    Anticancer Res; 1999; 19(2A):1021-6. PubMed ID: 10368649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine.
    Somerville L; Cory JG
    Int J Oncol; 2000 Oct; 17(4):797-803. PubMed ID: 10995894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.
    He AW; Cory JG
    Int J Oncol; 1999 May; 14(5):891-5. PubMed ID: 10200338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.
    He AW; Cory JG
    Oncol Res; 1998; 10(9):455-64. PubMed ID: 10223621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of cyclin cdk's, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol, LY 294002, roscovitine,wortmannin and UCN-01.
    Cory AH; Somerville L; Cory JG
    Anticancer Res; 2005; 25(1A):101-6. PubMed ID: 15816525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
    Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Cory AH; Hertel LW; Kroin JS; Cory JG
    Oncol Res; 1993; 5(2):59-63. PubMed ID: 8364254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH; Samano V; Robins MJ; Cory JG
    Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
    Cory JG; He AW; Cory AH
    Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
    Dinkova-Kostova AT; Cory AH; Bozak RE; Hicks RJ; Cory JG
    Cancer Lett; 2007 Jan; 245(1-2):341-9. PubMed ID: 16517063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines.
    He AW; Cory JG
    Anticancer Res; 1999; 19(1A):421-8. PubMed ID: 10226577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.